The DOI matches its Crossref record.
Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“RKIP loss and/or dysregulation have been linked to many diseases, including metastatic lesions, asthma, Alzheimer’s disease, systemic inflammatory response syndrome, and heart disease (4–10).”
From Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop (2022) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 43
- Landis, 1998, CA Cancer J Clin, 48, 6, 10.3322/canjclin.48.1.6 · DOI · Paper page
- Lerner, 1991, J Urol, 146, 1040, 10.1016/S0022-5347(17)37997-1 · doi:10.1016/s0022-5347(17)37997-1
- Schellhammer, 1988, Urology, 31, 191, 10.1016/0090-4295(88)90137-9 · doi:10.1016/0090-4295(88)90137-9
- Roberts, 2001, Urology, 57, 1033, 10.1016/S0090-4295(01)00978-5 · doi:10.1016/s0090-4295(01)00978-5
- Fu, 2002, Prostate, 51, 10, 10.1002/pros.10056 · DOI
- Perry, 1994, Biochem J, 301, 235, 10.1042/bj3010235 · doi:10.1042/bj3010235
- Tohdoh, 1995, Brain Res Mol Brain Res, 30, 381, 10.1016/0169-328X(95)00029-R · doi:10.1016/0169-328x(95)00029-r
- Yeung, 1999, Nature, 401, 173, 10.1038/43686 · DOI · Paper page
- Yeung, 2001, Mol Cell Biol, 21, 7207, 10.1128/MCB.21.21.7207-7217.2001 · DOI · Paper page
- Lorenz, 2003, Nature, 426, 574, 10.1038/nature02158 · DOI · Paper page
- Fu, 2003, J Natl Cancer Inst, 95, 878, 10.1093/jnci/95.12.878 · DOI · Paper page
- Rhodes, 2004, Neoplasia, 6, 1, 10.1016/S1476-5586(04)80047-2 · DOI · Paper page
- Rubin, 2000, Clin Cancer Res, 6, 1038
- Perrone, 2000, J Natl Cancer Inst, 92, 937, 10.1093/jnci/92.11.937 · DOI
- Kononen, 1998, Nat Med, 4, 844, 10.1038/nm0798-844 · DOI · Paper page
- Gleason, 1966, Cancer Chemother Rep, 50, 125
- Manley, 2001, Am J Pathol, 159, 837, 10.1016/S0002-9440(10)61759-2 · DOI
- Dhanasekaran, 2001, Nature, 412, 822, 10.1038/35090585 · DOI · Paper page
- Pound, 1999, Jama, 281, 1591, 10.1001/jama.281.17.1591 · DOI · Paper page
- Ayala, 2003, Clin Cancer Res, 9, 4792
- Ayala, 2003, Cancer Res, 63, 6244
- Dash, 2002, Urology, 60, 276, 10.1016/S0090-4295(02)01727-2 · doi:10.1016/s0090-4295(02)01727-2
- Liu, 2003, Clin Cancer Res, 9, 1393
- Schindl, 2000, Anticancer Res, 20, 4551
- Liu, 2000, Gynecol Oncol, 78, 10, 10.1006/gyno.2000.5801 · doi:10.1006/gyno.2000.5801
- Lee, 2003, Cancer Res, 63, 7247
- Ikeguchi, 2003, J Cancer Res Clin Oncol, 129, 531, 10.1007/s00432-003-0469-z · DOI
- Niitsu, 2003, Leukemia, 17, 196, 10.1038/sj.leu.2402699 · doi:10.1038/sj.leu.2402699
- Muller, 1998, Cancer, 83, 2481, 10.1002/(SICI)1097-0142(19981215)83:12<2481::AID-CNCR11>3.0.CO;2-P · doi:10.1002/(sici)1097-0142(19981215)83:12<2481::aid-cncr11>3.0.co;2-p
- Szumilo, 2002, Folia Histochem Cytobiol, 40, 377
- Masuda, 2000, Head Neck, 22, 662, 10.1002/1097-0347(200010)22:7<662::AID-HED4>3.0.CO;2-O · doi:10.1002/1097-0347(200010)22:7<662::aid-hed4>3.0.co;2-o
- Gonzalez-Moles, 2003, Anticancer Res, 23, 5197
- Partin, 1997, Jama, 277, 1445, 10.1001/jama.1997.03540420041027 · doi:10.1001/jama.1997.03540420041027
- Etzioni, 2002, J Natl Cancer Inst, 94, 981, 10.1093/jnci/94.13.981 · DOI · Paper page
- Stamey, 2002, J Urol, 167, 103, 10.1016/S0022-5347(05)65392-X · DOI · Paper page
- Gleason, 1974, J Urol, 111, 58, 10.1016/S0022-5347(17)59889-4 · DOI · Paper page
- Epstein, 1993, Cancer, 71, 3582, 10.1002/1097-0142(19930601)71:11<3582::AID-CNCR2820711120>3.0.CO;2-Y · doi:10.1002/1097-0142(19930601)71:11<3582::aid-cncr2820711120>3.0.co;2-y
- Schroder, 2000, J Urol, 163, 806, 10.1016/S0022-5347(05)67809-3 · doi:10.1016/s0022-5347(05)67809-3
- Zincke, 1994, J Urol, 152, 1850, 10.1016/S0022-5347(17)32399-6 · DOI · Paper page
- Han, 2001, Urol Clin North Am, 28, 555, 10.1016/S0094-0143(05)70163-4 · DOI · Paper page
- Roberts, 2001, Mayo Clin Proc, 76, 576, 10.1016/S0025-6196(11)62406-3 · DOI · Paper page
- Pettaway, 1998, Tech Urol, 4, 35
- Blute, 2001, J Urol, 165, 119, 10.1097/00005392-200101000-00030 · DOI · Paper page
Cited by
Lee, J., Olivieri, C., Ong, C., Masterson, L. R., Gomes, S., Lee, B.-S., Schaefer, F., Lorenz, K., Veglia, G., & Rosner, M. R. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2121867119 · Cited by 20
Metadata
- Authors
- Fu, Z., Kitagawa, Y., Shen, R., Shah, R., Mehra, R., Rhodes, D., Keller, P. J., Mizokami, A., Dunn, R., Chinnaiyan, A. M., Yao, Z., & Keller, E. T.
- Venue
- The Prostate
- Publisher
- Wiley
- Published
- 2006-02-15
- Volume
- 66
- Issue
- 3
- Pages
- 248-256
- ISSN
- 0270-4137
- 1097-0045
- Cited by
- 160
- References
- 0
- Language
- en
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 3485 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. https://app.cochat.ai/papers/10.1002/pros.20319
- The paper
- Fu, Z., Kitagawa, Y., Shen, R., Shah, R., Mehra, R., Rhodes, D., Keller, P. J., Mizokami, A., Dunn, R., Chinnaiyan, A. M., Yao, Z., & Keller, E. T. (2006). Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. The Prostate. https://doi.org/10.1002/pros.20319
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.